Identifying patients with pharmacoresistant epilepsy using a plasma-based test
S. Avansini, B. Lima, R. Secolin, M. Santos, A. C. Coan, A. Vieira, B. Carvalho, M. Alvim, F. Torres, L. Silva, F. Rogerio, F. Cendes, I. Lopes-Cendes
ARTIGO
Inglês
Refractory epilepsy occurs in~30% of all patients and majorcauses are focal cortical dysplasia (FCD) and mesial temporal epilepsy(MTLE). Epilepsy surgery can be performed in order to achieve seizurecontrol, nevertheless, this indication may be may delayed
Fechado
Secolin, Rodrigo, 1978-
Autor
Santos, Marilza de Lima
Autor
DOI: https://doi.org/10.1111/epi.13241
Texto completo: http://onlinelibrary.wiley.com/doi/10.1111/epi.13241
Identifying patients with pharmacoresistant epilepsy using a plasma-based test
S. Avansini, B. Lima, R. Secolin, M. Santos, A. C. Coan, A. Vieira, B. Carvalho, M. Alvim, F. Torres, L. Silva, F. Rogerio, F. Cendes, I. Lopes-Cendes
Identifying patients with pharmacoresistant epilepsy using a plasma-based test
S. Avansini, B. Lima, R. Secolin, M. Santos, A. C. Coan, A. Vieira, B. Carvalho, M. Alvim, F. Torres, L. Silva, F. Rogerio, F. Cendes, I. Lopes-Cendes
Fontes
|
Epilepsia (Fonte avulsa) |